Antiviral Activity of Technologically Processed Antibodies to CD4 Receptor against Influenza Infection

The antiviral activity of technologically processed antibodies to CD4 receptor was evaluated a model of sublethal A/California/04/2009 (H1N1)pdm09-induced influenza infection in female BALB/c mice. The technologically processed antibodies increased animal survival rate by 50% in comparison with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrova, N. V., Emelyanova, A. G., Tarasov, S. A., Glubokova, Е. А., Каrtashova, N. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812737/
https://www.ncbi.nlm.nih.gov/pubmed/36600043
http://dx.doi.org/10.1007/s10517-023-05683-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812737/
https://www.ncbi.nlm.nih.gov/pubmed/36600043
http://dx.doi.org/10.1007/s10517-023-05683-8

Ejemplares similares